These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27169483)

  • 1. Hybrid antibiotics - clinical progress and novel designs.
    Parkes AL; Yule IA
    Expert Opin Drug Discov; 2016 Jul; 11(7):665-80. PubMed ID: 27169483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel heterodimer antibiotics: a review of recent patent literature.
    Long DD; Marquess DG
    Future Med Chem; 2009 Sep; 1(6):1037-50. PubMed ID: 21425993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance.
    Pokrovskaya V; Baasov T
    Expert Opin Drug Discov; 2010 Sep; 5(9):883-902. PubMed ID: 22823262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxazolidinone antimicrobials: a patent review (2012-2015).
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class.
    Nilius AM
    Curr Opin Investig Drugs; 2003 Feb; 4(2):149-55. PubMed ID: 12669374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies.
    Baquero F; Coque TM; Cantón R
    Expert Opin Ther Targets; 2014 Aug; 18(8):851-61. PubMed ID: 24881465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New oxazolidinones.
    Vara Prasad JV
    Curr Opin Microbiol; 2007 Oct; 10(5):454-60. PubMed ID: 17928263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent derivatives from smaller classes of fermentation-derived antibacterials.
    Kirst HA
    Expert Opin Ther Pat; 2012 Jan; 22(1):15-35. PubMed ID: 22136593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance in bacteria and its future for novel antibiotic development.
    Yoneyama H; Katsumata R
    Biosci Biotechnol Biochem; 2006 May; 70(5):1060-75. PubMed ID: 16717405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where will new antibiotics come from?
    Walsh C
    Nat Rev Microbiol; 2003 Oct; 1(1):65-70. PubMed ID: 15040181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    J Appl Microbiol; 2002; 92 Suppl():4S-15S. PubMed ID: 12000608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial agents: patent highlights January to June 2003.
    Phillips OA
    Curr Opin Investig Drugs; 2003 Aug; 4(8):926-36. PubMed ID: 14508876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics in development targeting protein synthesis.
    Sutcliffe JA
    Ann N Y Acad Sci; 2011 Dec; 1241():122-52. PubMed ID: 22191530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel oxazolidinone antibiotic: RWJ-416457.
    Cheung EY; Peterson ML; Chiarella R; Foxman BM
    Acta Crystallogr C; 2010 May; 66(Pt 5):o249-51. PubMed ID: 20442508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.